Your browser doesn't support javascript.
loading
Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing.
Baby, Santhosh M; May, Walter J; Getsy, Paulina M; Coffee, Gregory A; Nakashe, Tej; Bates, James N; Levine, Alan; Lewis, Stephen J.
Afiliación
  • Baby SM; Department of Drug Discovery, Galleon Pharmaceuticals, Inc., Horsham, PA, United States.
  • May WJ; Pediatric Respiratory Medicine, University of Virginia School of Medicine, Charlottesville, VA, United States.
  • Getsy PM; Department of Pediatrics, Case Western Reserve University, Cleveland, OH, United States.
  • Coffee GA; Department of Pediatrics, Case Western Reserve University, Cleveland, OH, United States.
  • Nakashe T; Department of Biological Sciences, Kent State University, Kent, OH, United States.
  • Bates JN; Department of Anesthesiology, University of Iowa Hospitals and Clinics, Iowa City, IO, United States.
  • Levine A; Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH, United States.
  • Lewis SJ; Department of Pediatrics, Case Western Reserve University, Cleveland, OH, United States.
Front Pharmacol ; 15: 1381073, 2024.
Article en En | MEDLINE | ID: mdl-38698814
ABSTRACT
Fentanyl elicits profound disturbances in ventilatory control processes in humans and experimental animals. The traditional viewpoint with respect to fentanyl-induced respiratory depression is that once the effects on the frequency of breathing (Freq), tidal volume (TV), and minute ventilation (MV = Freq × TV) are resolved, then depression of breathing is no longer a concern. The results of the present study challenge this concept with findings, as they reveal that while the apparent inhibitory effects of fentanyl (75 µg/kg, IV) on Freq, TV, and MV in adult male rats were fully resolved within 15 min, many other fentanyl-induced responses were in full effect, including opposing effects on respiratory timing parameters. For example, although the effects on Freq were resolved at 15 min, inspiratory duration (Ti) and end inspiratory pause (EIP) were elevated, whereas expiratory duration (Te) and end expiratory pause (EEP) were diminished. Since the effects of fentanyl on TV had subsided fully at 15 min, it would be expected that the administration of an opioid receptor (OR) antagonist would have minimal effects if the effects of fentanyl on this and other parameters had resolved. We now report that the intravenous injection of a 1.0 mg/kg dose of the peripherally restricted OR antagonist, methyl-naloxone (naloxone methiodide, NLXmi), did not elicit arousal but elicited some relatively minor changes in Freq, TV, MV, Te, and EEP but pronounced changes in Ti and EIP. In contrast, the injection of a 2.5 mg/kg dose of NLXmi elicited pronounced arousal and dramatic changes in many variables, including Freq, TV, and MV, which were not associated with increases in non-apneic breathing events such as apneas. The two compelling conclusions from this study are as follows 1) the blockade of central ORs produced by the 2.5 mg/kg dose of NLXmi elicits pronounced increases in Freq, TV, and MV in rats in which the effects of fentanyl had apparently resolved, and 2) it is apparent that fentanyl had induced the activation of two systems with counter-balancing effects on Freq and TV one being an opioid receptor inhibitory system and the other being a non-OR excitatory system.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos